XtalPi Holdings Limited
Total Valuation
USDAs of December 31, 2025, QUANTUMPHARM INC. carries a market capitalization of 5.22B, placing it among publicly traded companies globally. Its enterprise value stands at 4.28B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 5.22B |
| Enterprise Value | 4.28B |
Important Dates
QUANTUMPHARM INC.'s next confirmed earnings release is scheduled for April 1, 2027.
| Earnings Date | 4/1/2027 |
Share Statistics
As of December 31, 2025, QUANTUMPHARM INC. has 4.30B shares outstanding.
| Shares Outstanding | 4.30B |
Valuation Ratios
These figures are as of December 31, 2025.
| PB Ratio | 3.89 |
| P/TBV Ratio | 3.99 |
Financial Position
As of December 31, 2025, QUANTUMPHARM INC. maintains a current ratio of 14.77, meaning it holds 14.8x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 14.77 |
| Quick Ratio | 13.95 |
| Debt / Equity | 4.69 |
Financial Efficiency
These figures cover the twelve months ended December 31, 2025.
| Employee Count | 1,031.50 |
Stock Price Statistics
USDAs of the close on October 19, 2026, QUANTUMPHARM INC.'s stock has declined approximately 61.99% over the past 52 weeks.
| 52-Week Price Change | -61.99% |
| 50-Day Moving Average | 1.08 |
Balance Sheet
USDAs of December 31, 2025, QUANTUMPHARM INC. holds 1.01B in cash and equivalents against 63.19M in total debt, resulting in a net debt position of -318.52M. Total book value stands at 1.34B, with working capital of 995.51M providing operational flexibility.
| Cash & Cash Equivalents | 1.01B |
| Total Debt | 63.19M |
| Net Debt | -318.52M |
| Equity (Book Value) | 1.34B |
| Book Value Per Share | 0.31 |
| Working Capital | 995.51M |